Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein
October 12th, 2017
We describe here a fluorometric cell-free biochemical assay for determination of HDL-lipid peroxidation. This rapid and reproducible assay can be used to determine HDL function in large scale studies and can contribute to our understanding of HDL function in human disease.
The overall goal of this experimental method is to determine the function of high density lipoprotein using a biochemical cell-free assay that measures the lipid peroxide content of a specific amount of HDL. This method can help answer key questions in several fields of medicine, such as the role of HDL function in cardiovascular disease metabolic abnormalities. The main advantage of this technique is that it is a cell-free biochemical method that can be used to reliably determine HDL function.
Though this method can provide insight into the role of HDL function in cardiovascular disease and metabolic abnormalities, it can also be applied to other studies of disease, such as inflammatory diseases. To begin this procedure, prepare the working layout for the 96-well plate, including the appropriate controls, samples and replicates, as outlined in the text protocol. Calculate the volume of reagents needed based on the number of samples and replicates.
Using a permanent marker, label tubes for each step in the assay. Next, combine 10 microliters from each sample to create a pooled control sample. Create a second pooled control sample for the clinical laboratory, in order to determine the HDL-C value.
After preparing a large stock of HDL, cryo-preserve several aliquots to minimize freeze thaw cycles. Pool at least 10 different replicates to create a pooled quality control. Then, determine the average value of HDLox as outlined in the text protocol.
Create a second pooled quality control for the clinical laboratory, in order to determine the HDL-C value. To begin, thaw a fresh plasma or serum sample. Mix together equal volumes of plasma and HDL cholesterol precipitating reagent.
Pipette up and down several times to mix well. Centrifuge at a speed between 1000 and 2000 times G for 10 minutes. After this, aspirate the supernatant.
Store the isolated HDL at four degrees Celsius until ready to perform the fluorochrome HDL function assay. If the clinical laboratory's HDL-C value is used to normalize HDLox, quantify the HDL-C from plasma as outlined in the text protocol. To begin, mix cholesterol and HRP, such that the prepared solutions contain five units per milliliter of HRP.
Thaw a vial of fluorochrome reagent and a vial of DMSO to room temperature. After they are thawed, dissolve one milligram of fluorochrome reagent in 200 microliters of DMSO. Store this solution at a temperature below minus 20 degrees Celsius, while protected from light.
Next, add 50 microliters of 1X reaction buffer to the sample plate as a negative control. Add 50 microliters of 20 millimolar hydrogen peroxide working solution as a positive control. After this, set out a fresh round bottom 96-well plate to be used as the preparation plate.
Add 200 microliters of isolated HDL to each well of this preparation plate. Using a multichannel pipette, transfer 50 microliters of HDL from the preparation plate to the experimental plates, as outlined in the text protocol, with the number of experimental plates being equal to the number of replicates in the assay. After this, add 50 microliters of prepared HRP solution to each well.
Incubate at 37 degrees Celsius for 30 minutes, then add 50 microliters of fluorochrome reagent to each well, for a total volume of 150 microliters per well. Mix well and protect from light. Using a fluorescent plate reader, assess the fluorescent readout at 37 degrees Celsius, in the dark, every minute for 120 minutes.
Record the data using appropriate software, then calculate the mean value of fluorescence units as outlined in the text protocol. In this study, a cell-free biochemical fluorometric assay is developed to quantify the HDL lipid peroxide content per milligram of HDL-C. This is accomplished by enzymatic amplification using HRP.
A fluorescent plate reader is then used to measure the fluorescence in the dark, every minute, for 120 minutes. Representative data for a patient known to have dysfunctional HDL is shown here, compared to the pooled control. The dysfunctional HDL is seen to have lipid peroxide levels two-fold higher than those seen in the pooled HDL from healthy participants.
Next, the HDL is isolated and HDLox is determined in 50 healthy subjects and 100 HIV infected patients. The HIV infected patients are seen to have, on average, 60%higher HDL peroxide content per milligram of HDL-C than the healthy subjects. Once mastered, this technique can be done in under six hours if it is performed properly.
While attempting this procedure, it's important to remember to prepare all reagents and controls upfront, be consistent, precise and always include the appropriate experimental control in each experimental plate. After watching this video, you should have a good understanding of how to isolate the HDL, determine the lipid peroxide content of a specific amount of HDL and to depredate our regarding HDL function. Don't forget that working with biospecimens can be extremely hazardous and precautions, such as gloves, should always be taken while performing this procedure.
View the full transcript and gain access to thousands of scientific videos
Overview
This article presents a fluorometric cell-free biochemical assay designed to determine HDL-lipid peroxidation. The assay is rapid, reproducible, and can be utilized in large-scale studies to enhance our understanding of HDL function in human diseases.
Key Study Components
Area of Science
- Biochemistry
- Cardiovascular Research
- Metabolic Disorders
Background
- High-density lipoprotein (HDL) plays a crucial role in cardiovascular health.
- Understanding HDL function is vital for addressing metabolic abnormalities.
- Existing methods for assessing HDL function may be limited in scalability.
- This assay offers a new approach to measure HDL lipid peroxidation effectively.
Purpose of Study
- To develop a reliable method for assessing HDL function.
- To investigate the relationship between HDL function and cardiovascular disease.
- To provide insights into HDL's role in various diseases, including inflammatory conditions.
Methods Used
- Preparation of a 96-well plate layout with controls and samples.
- Calculation of reagent volumes based on sample numbers.
- Fluorometric measurement of lipid peroxide content in HDL.
- Analysis of results to determine HDL function.
Main Results
- The assay demonstrated rapid and reproducible results.
- It effectively quantified HDL lipid peroxidation levels.
- The method can be applied in large-scale studies.
- Insights gained can inform research on cardiovascular and metabolic diseases.
Conclusions
- The developed assay is a valuable tool for studying HDL function.
- It has potential applications in understanding various diseases.
- Future studies can leverage this method to explore HDL's role in health and disease.
Frequently Asked Questions
Executive Industry Relevance
This cell-free biochemical fluorometric assay provides a standardized, reproducible method to quantify lipid peroxidation in HDL, addressing a key limitation of cell-based HDL function assays. By enabling high-throughput measurement of HDL oxidative status, the assay supports target validation and mechanistic de-risking in cardiovascular and metabolic disease research. Its ability to correlate HDL lipid peroxide content with dysfunction phenotypes offers predictive value for prioritizing therapeutic candidates in atherosclerosis and inflammatory disease pipelines.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Scientific Value: Enables interrogation of HDL's role in lipid peroxide transport and antioxidant function, clarifying mechanistic links between oxidative stress and HDL dysfunction.
- Operational Value: Provides a cell-free system that reduces biological variability, supporting consistent target engagement assessment across compound screens.
Screening & Assay Development
- Scientific Value: Generates quantitative lipid peroxide readouts per mg HDL-C, enabling dose-response analysis of compounds that modulate HDL oxidation.
- Operational Value: Uses fluorometric detection compatible with 96-well plate formats, facilitating assay standardization and scalability for medium-throughput screening.
Translational & Preclinical Research
- Scientific Value: Demonstrates disease relevance by showing elevated HDLox in HIV-infected patients versus healthy subjects, supporting biomarker qualification efforts.
- Operational Value: Outputs correlate with validated cell-based assays and systemic inflammation measures, enabling cross-platform continuity in preclinical validation workflows.
Pipeline & Workflow Integration
The assay fits within the discovery continuum from early target validation through preclinical assessment, particularly for programs targeting HDL function in cardiovascular and metabolic disorders.
- Discovery Biology: Supports hypothesis testing regarding HDL's antioxidant capacity and its impairment in inflammatory states through direct measurement of lipid peroxidation.
- Screening: Delivers reproducible, quantitative fluorescence readouts that enable comparison of test conditions against controls with defined thresholds for HDLox elevation.
- Analytics: Provides continuous lipid peroxide concentration data per mg HDL-C, allowing statistical comparison of HDL functional states across patient cohorts or treatment groups.
- Translational Research: Connects to preclinical continuity by linking HDL oxidation levels to functional outcomes observed in cell-based efflux assays and cardiovascular risk phenotypes.
- Enterprise Reuse: Establishes a reusable biochemical platform for assessing HDL function across multiple disease models, reducing reliance on variable cell-based systems.
Operational & Enterprise Impact
- Scientific Value: Increases predictive confidence in HDL-targeted interventions by directly measuring a mechanistic driver of dysfunction—lipid peroxide accumulation.
- Operational Value: Enhances reproducibility through strict standardization of reagent preparation, incubation conditions, and fluorescence measurement protocols.
- Strategic Value: Improves go/no-go decision-making by providing an objective, quantitative biomarker of HDL oxidative status that complements functional assays.
- Portfolio Impact: Enables risk-adjusted prioritization of compounds based on their impact on HDL lipid peroxidation, reducing late-stage failure due to unidentified oxidative liabilities.
Implementation Considerations
- Requires expertise in lipoprotein isolation, enzymatic assay setup, and fluorescence detection using plate readers.
- Dependent on access to fluorometric plate readers capable of kinetic measurements and HDL isolation reagents such as cholesterol precipitating agents.
- Necessitates cross-team standardization of HDL preparation, control sample pooling, and replicate testing to minimize inter-assay variability.
- Adaptation to alternative lipoprotein fractions (e.g., LDL, VLDL) would require validation of enzyme specificity and interference controls.
- Practical limitations include sensitivity to light exposure of the Amplex Red reagent and the need to avoid cholesterol oxidase interference in HDL-C normalization steps.
Biopharma FAQs
Chapters in this video
0:05
Title
0:58
Day 1: Preparation of Controls and Laboratory-specific Quality Controls
2:10
Day 1: Separation of HDL Cholesterol using HDL Precipitation
3:07
Day 2: Fluorochrome Assay
5:17
Results: Cell-free Biochemical Fluorometric Assay Results
6:32
Conclusion
